Clinical Trials Directory

Trials / Completed

CompletedNCT04035161

Evaluation of the Antimicrobial Effectiveness of CHG/IPA

Evaluation of the Antimicrobial Effectiveness of CHG/IPA in Healthy Volunteers

Status
Completed
Phase
Study type
Interventional
Enrollment
1,935 (actual)
Sponsor
Becton, Dickinson and Company · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This single site study is a randomized, controlled, partially-blinded design enrolling a minimum of 516 healthy volunteers, where each subject will receive two of the planned study products on the product application sites of the abdomen and/or groin.

Detailed description

To demonstrate the antimicrobial activity of the Investigational Product (IP) by comparing counts of resident skin microbes, obtained after IP application to intact skin of the abdomen and groin, to counts obtained prior to application.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTInvestigational Product2%(w/v) Chlorhexidine in 70%(v/v) Isopropyl skin preparation
OTHERReference Standard60% (v/v) 1-propanol skin preparation
COMBINATION_PRODUCTActive ComparatorChloraPrep® SEPP® skin preparation
OTHERNegative Control0.9% Normal Saline skin preparation

Timeline

Start date
2019-04-17
Primary completion
2019-12-24
Completion
2019-12-24
First posted
2019-07-29
Last updated
2021-08-17
Results posted
2021-08-17

Locations

1 site across 1 country: Romania

Source: ClinicalTrials.gov record NCT04035161. Inclusion in this directory is not an endorsement.